公司資料
CONMED 股價、新聞與催化劑
- 股票代碼:
- CNMD
- 交易所:
- NYSE
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
45.93 USD (-0.65%)
收盤價
最後更新: 2026年10月1日
1.02B USD
市值
股價為何變動
截至 2026年10月1日，CNMD 下跌 0.65%，收於 $45.93。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
Surgical Medical Technology Company
CONMED develops devices and equipment used by surgeons in orthopedics, general surgery, gynecology, thoracic surgery, and other minimally invasive specialties.
Orthopedic Surgery Portfolio
The orthopedic business includes sports-medicine implants, powered surgical instruments, visualization systems, and related disposable products used in arthroscopic and open procedures.
General Surgery Portfolio
General Surgery includes electrosurgical devices, smoke evacuation, insufflation, fluid management, and other products used in laparoscopic, robotic, and open surgery.
AirSeal and Buffalo Filter Platforms
AirSeal supports stable pneumoperitoneum and smoke evacuation during minimally invasive and robotic procedures, while Buffalo Filter provides surgical-smoke management. Both platforms combine installed equipment with procedure-based disposable demand.
BioBrace Soft-Tissue Reinforcement
BioBrace is a bioinductive scaffold used to reinforce soft-tissue repairs. It expands CONMED's exposure to sports-medicine procedures where surgeons seek both immediate mechanical strength and biological healing support.
未來催化劑
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。